Podcast: A Closer Look at Spravato (Esketamine) – Does Spravato require patients to be prescribed an antidepressant? 

A closer look at Spravato/Esketamine. This episode focuses on the definition of Treatment Resistant Depression and looks at whether patients must be prescribed to an antidepressant while using Spravato. Additionally, what does one do about co-occurring conditions such as anxiety, suicidal ideation, ocd, etc? 

Podcast: A Closer Look at Spravato (Esketamine) – What do we know about the prescribed dosing?

One thing that raised the eyebrows of everybody on the clinical team here at KWC relates to the recommended dosing of Spravato. On this episode, we discuss what the recommended dosing is during the stabilization and maintenance treatment phases. Is the dosing variable from patient to patient or fixed? What are the implications of utilizing a non-variable prescription for dosing?

CEO Update – March 2019

CEO Update – March 2019 THE GREATEST BREAKTHROUGH IN 30 YEARS FOR THE TREATMENT OF TREATMENT RESISTANT DEPRESSION IS SPRAVATO / ESKETAMINE!   Is it really? Or are they just confirming what we have known for the last eight years?  Yes, finally Johnson and Johnson has successfully received FDA approval to provide the medical community…